Dr. Sarah Van Den Hoek Graff

Dr. Sarah Van Den Hoek Graff (DR. SARAH VAN DEN HOEK GRAFF ) is A Psychiatry & Neurology Physician in Montague, MA. The NPI Number for Dr. Sarah Van Den Hoek Graff is 1346292398.

The current location address for Dr. Sarah Van Den Hoek Graff is 59A MAIN ST Montague, MA 01351 and the contact number is 4132309400 and fax number is . The mailing address for Dr. Sarah Van Den Hoek Graff is 59A MAIN ST PO BOX 24 Montague, MA 01351- 4132309400 (mailing address contact number - 4132309400).

A Psychiatrist specializes in the prevention, diagnosis, and treatment of mental disorders, emotional disorders, psychotic disorders, mood disorders, anxiety disorders, substance-related disorders, sexual and gender identity disorders and adjustment disorders. Biologic, psychological, and social components of illnesses are explored and understood in treatment of the whole person. Tools used may include diagnostic laboratory tests, prescribed medications, evaluation and treatment of psychological and interpersonal problems with individuals and families, and intervention for coping with stress, crises, and other problems.

What is the NPI Number for Dr. Sarah Van Den Hoek Graff ?

Answer: The NPI Number for Dr. Sarah Van Den Hoek Graff is 1346292398

Where is Dr. Sarah Van Den Hoek Graff located?

Answer: Dr. Sarah Van Den Hoek Graff is located at 59A MAIN ST Montague, MA 01351.

What is the specialty for Dr. Sarah Van Den Hoek Graff ?

Answer: The Specialty of Dr. Sarah Van Den Hoek Graff is A Psychiatry & Neurology Physician.

Are there any online reviews for Dr. Sarah Van Den Hoek Graff ?

Answer: Yes! Check It Now.

Are there any other health care providers in Montague, MA?

Answer: Yes, there are given below...

Information on prescription drugs provided to Medicare beneficiaries enrolled in Part D (Prescription Drug Coverage), by physicians and other health care providers, aggregated by provider.

Provider Specialty Type	Psychiatry & Neurology
Source of Provider Specialty
Number of Medicare Part D Claims, Including Refills	165
Number of Standardized 30-Day Fills	192
Aggregate Cost Paid for All Claims	7216.57
Number of Day's Supply for All Claims	5718
Number of Medicare Beneficiaries	11
Number of Claims, Including Refills, for Beneficiaries Age 65+	145
Including Refills, for Beneficiaries Age 65+	151
Beneficiaries Age 65+	6721.77
Number of Day's Supply for All Claims for Beneficaries Age 65+	4499
Number of Medicare Beneficiaries Age 65+
Reason for Suppression of Brnd_Tot_Clms and Brnd_Tot_Drug_Cst
Total Claims of Brand-Name Drugs	29
Reason for Suppression of Gnrc_Tot_Clms and Gnrc_Tot_Drug_Cst
Total Claims of Generic Drugs, Including Refills	136
Aggregate Cost Paid for Generic Drugs	1882.18
Reason for Suppression of Othr_Tot_Clms and Othr_Tot_Drug_Cst
Total Claims of Other Drugs, Including Refills	0
Aggregate Cost Paid for Other Drugs	0
Reason for Suppression of MAPD_Tot_Clmsand MAPD_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by MAPD Plans	31
Aggregate Cost Paid for Claims Filled by Beneficiaries in MAPD Plans	549.17
Reason for Suppression of PDP_Tot_Clms and PDP_Tot_Drug_Cst
Number of Claims for Beneficiaries Covered by Standalone PDP Plans	134
Aggregate Cost Paid for Claims Filled by	6667.4
Reason for Suppression of LIS_Tot_Clms and LIS_Drug_Cst
Number of Claims for Beneficiaries Covered by Low-Income Subsidy	0
Aggregate Cost Paid for Claims Covered by Low-Income Subsidy	0
Reason for Suppression of NonLIS_Tot_Clms and NonLIS_Drug_Cst
Number of Claims for Beneficiaries Not Covered by Low-Income Subsidy	165
by Low-Income Subsidy	7216.57
Total Claims of Opioid Drugs, Including	0
Aggregate Cost Paid for Opioid Drugs	0
Opioid Claims	0
Opioid_Tot_Clms divided by the Tot_Clms	0
Total Claims of Long-Acting Opioid Drugs	0
Aggregate Cost Paid for Long-Acting Opioid	0
Number of Day's Supply of All Long-Acting	0
Long-Acting Opioid Claims	0
Opioid_LA_Tot_Clms divided by the
Total Claims of Antibiotic Drugs, Including	0
Aggregate Cost Paid for Antibiotic Drugs	0
Antibiotic Claims	0
Reason for Suppression of Antpsyct_GE65_Tot_Clms and Antpsyct_GE65_Tot_Drug_Cst
Including Refills, for Beneficiaries Age 65+	25
Aggregate Cost Paid for AntipsychoticDrugs for Beneficiaries Age 65+	252.97
Reason for Suppression of Antpsyct_GE65_Tot_Benes
Number of Medicare Beneficiaries Age 65+Filling Antipsychotic Claims
Average Age of Beneficiaries	68.727272727
Number of Beneficiaries Age Less Than 65
Number of Beneficiaries Age 65 to 74
Number of Beneficiaries Age 75 to 84
Number of Female Beneficiaries
Number of Male Beneficiaries
Number of Non-Hispanic White
Number of Black or African American	0
Number of Asian Pacific Islander	0
Number of Hispanic Beneficiaries	0
Number of American Indian/Alaskan NativeBeneficiaries	0
Number of Beneficiaries with Race Not
Only Entitlement	11
Average Hierarchical Condition Category	0.8567272727